WallStreetZenWallStreetZen

NYSE: DHR
Danaher Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Danaher earnings were $3.8B for the trailing 12 months ending Mar 28, 2025, with -12.9% growth year over year. The latest DHR earnings report on Mar 28, 2025 announced Q1 2025 earnings of $954.0M, down 12.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, DHR reported annual earnings of $3.9B, with -17.8% growth. The next DHR earnings date is Jul 22, 2025.

DHR past earnings growth

How has DHR's earnings growth performed historically?

Company
-12.92%
Industry
3.84%
Market
34.26%
DHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
DHR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
DHR's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

DHR earnings history

Current Revenue
$23.8B
Current Earnings
$3.8B
Current Profit Margin
15.8%
DHR's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

DHR Return on Equity

Current Company
7.5%
Current Industry
-10.3%
Current Market
31.3%
DHR's Return on Equity (7.5%)... subscribe to Premium to read more.
High Return on Equity Performance

DHR undefined

Current Company
4.8%
Current Industry
6%
DHR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when DHR announces earnings.

DHR undefined

Current Company
6.61%
Current Industry
10.8%
DHR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DHR vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
DHR$7.15B$3.77B+3.03%$5.19
TMO$11.29B$6.52B+13.21%$17.09
IDXX$1.29B$894.97M+16.49%$10.92
A$1.76B$1.17B+12.99%$4.07
IQV$3.43B$1.33B+45.92%$7.41
View Top Diagnostic & Research Stocks

DHR earnings dates

Next earnings date
Jul 22, 2025

Danaher Earnings Reports & History FAQ

What were Danaher's earnings last quarter?

On DHR's earnings call on Invalid Date, Danaher (NYSE: DHR) reported Q1 2025 earnings per share (EPS) of $1.33, up 9.52% year over year. Total DHR earnings for the quarter were $954.00 million. In the same quarter last year, Danaher's earnings per share (EPS) was $1.47.

If you're new to stock investing, here's how to buy Danaher stock.

When does Danaher report earnings?

The next DHR earnings call is Invalid Date. Add DHR to your watchlist to be reminded of Danaher's next earnings date.

Is Danaher profitable or losing money?

As of the last Danaher earnings report, Danaher is currently profitable. Danaher's net profit (also called net income) for the twelve months ending Mar 28, 2025 was $3.77 billion, a 14.47% decrease year over year.

What was DHR's earnings growth in the past year?

As of Danaher's earnings date in Invalid Date, Danaher's earnings has grown -12.92% year over year. This is 16.76 percentage points lower than the US Diagnostics & Research industry earnings growth rate of 3.84%. DHR earnings in the past year totalled $3.77 billion.

What are Danaher's earnings expectations?

The current EPS estimate for Danaher's earnings report in Invalid Date is $1.64.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.